June 2007
Worldwide Biotech;Jun2007, Vol. 19 Issue 6, p1
Trade Publication
The article announces that TopoTarget AS has started the Avugane phase II trial for acne vulgaris. The double-blind, randomized study will investigate the efficacy and safety in a four-armed trial with three different dose strengths of topically applied Avugane in the treatment of mild to moderate acne vulgaris in comparison with a placebo controlled study arm. Patients in this trial will be treated over 12 weeks.


Related Articles

  • Double-Blind, Placebo-Controlled Evaluation of Clinical Activity and Safety of Daflon 500 mg in the Treatment of Acute Hemorrhoids. Cospite, M. // Angiology;Jun1994 Supplement, Vol. 45, p566 

    One hundred patients with a history of hemorrhoidal disease and suffering from an acute hemorrhoidal attack were randomized into two parallel groups and treated with Daflon 500 mg (D500) or placebo (PL) under double-blind conditions. Daflon 500 mg was administered at the dosage of three tablets...

  • Daflon 500 mg in the Treatment of Hemorrhoidal Disease: A Demonstrated Efficacy in Comparison with Placebo. Godeberge, Phillipe // Angiology;Jun1994 Supplement, Vol. 45, p574 

    Hemorrhoidal disease (HD) is a trophic disorder of the anal canal characterized by recurrent, self-resolving acute episodes. The author reports the results of a double-blind, placebo-controlled trial of the efficacy of Daflon 500 mg in the treatment of acute and chronic symptoms of hemorrhoids....

  • Clinical trial: active control vs placebo--What is ethical? Splawinski, Jacek; Kuzniar, Jerzy // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p73 

    The quest for effective medicines is very old. In modern times two important tools have been developed to evaluate efficacy of' drugs: superiority and non-inferiority types of clinical trials. The former tests the null hypothesis of μ (the difference between a tested drug and comparator)...

  • Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy. McClellan, K.J.; Spencer, C.M. // CNS Drugs;1998, Vol. 9 Issue 4, p311 

    Synopsis: Modafinil promotes wakefulness through an as yet unknown mechanism of action. It significantly increases daytime sleep latency and reduces excessive daytime sleepiness (EDS) compared with placebo in patients with narcolepsy. However, the drug does not suppress cataplexy....

  • Expert comments. Mandhani, Anil // Indian Journal of Urology;Jun2006, Vol. 22 Issue 2, p134 

    Presents the author's views on the safety and effectiveness of the Dutasteride in the treatment of urinary retention. Comparison between the effectiveness of Dutasteride and Finasteride; Improvement of symptoms in patients administered with placebo treatments;

  • Doxazosin plus finasteride reduced clinical progression of benign prostatic hyperplasia more than either drug used alone. Hoffman, Richard // ACP Journal Club;Jul/Aug2004, Vol. 141 Issue 1, p20 

    Doxazosin plus finasteride reduced clinical progression of benign prostatic hyperplasia more than either drug used alone. In men with benign prostatic hyperplasia, long-term doxazosin plus finasteride combination therapy reduced the risk for overall clinical progression of benign prostatic...

  • Fluoxetine for Depersonalization Disorder: Lack of Efficacy.  // Child & Adolescent Psychopharmacology News;Aug2004, Vol. 9 Issue 5, p10 

    The article cites a research study conducted to determine the efficacy of the use of fluoxetine for the treatment of depersonalization disorder. A total of 54 patients were selected for this study and they were adults aged between 18-65 years. By semi-structured clinical interview, these...

  • Assessing the efficacy of drugs for the acute treatment of migraine: issues in clinical trial design. Ramadan, N.M.; Ramadan, Nabih M // CNS Drugs;2002, Vol. 16 Issue 3, p181 

    Clinical trials of therapies for acute migraine attacks have evolved over the years from open-label, small observational studies to highly structured randomised, controlled trials. The International Headache Society Committee on Clinical Trials in Migraine developed a tool to guide in designing...

  • N-of-1 trials cost effective in Australian setting.  // PharmacoEconomics & Outcomes News;3/8/2008, Issue 548, p7 

    The article discusses research being done on the effectiveness of N-of-1 trials as option for increasing patients' access to high-cost medications in the Australian setting. It references a study by P. A. Scuffham et al, published in the January-February 2008 issue of "Value in Health." The data...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics